| Auranofin: repurposing an old drug for a golden new age C Roder, MJ Thomson Drugs in r&d 15, 13-20, 2015 | 537 | 2015 |
| Australasian Society of Infectious Diseases updated guidelines for the management of Clostridium difficile infection in adults and children in Australia and New Zealand JA Trubiano, AC Cheng, TM Korman, C Roder, A Campbell, MLA May, ... Internal Medicine Journal 46 (4), 479-493, 2016 | 142 | 2016 |
| Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings RK Gupta, CJ Calderwood, A Yavlinsky, M Krutikov, M Quartagno, ... Nature medicine 26 (12), 1941-1949, 2020 | 82 | 2020 |
| Aiming for elimination: outcomes of a consultation pathway supporting regional general practitioners to prescribe direct acting antiviral therapy for hepatitis C. AJ Wade, A McCormack, C Roder, K McDonald, M Davies, N Scott, ... Journal of Viral Hepatitis 25 (9), 1089-1098, 2018 | 34 | 2018 |
| Area‐level social and economic factors and the local incidence of SARS‐CoV‐2 infections in Victoria during 2020 C Roder, C Maggs, BJ McNamara, D O'Brien, AJ Wade, C Bennett, ... Medical Journal of Australia 216 (7), 349-356, 2022 | 23 | 2022 |
| High Effectiveness of Broad Access Direct‐Acting Antiviral Therapy for Hepatitis C in an A ustralian Real‐World Cohort: The REACH‐C Study J Yee, JM Carson, B Hajarizadeh, J Hanson, J O’Beirne, D Iser, P Read, ... Hepatology communications 6 (3), 496-512, 2022 | 19 | 2022 |
| In Vitro Investigation of Auranofin as a Treatment for Clostridium difficile Infection C Roder, E Athan Drugs in R&D 20, 209-216, 2020 | 14 | 2020 |
| Retreatment for hepatitis C virus direct‐acting antiviral therapy virological failure in primary and tertiary settings: The REACH‐C cohort JM Carson, B Hajarizadeh, J Hanson, J O'Beirne, D Iser, P Read, ... Journal of viral hepatitis 29 (8), 661-676, 2022 | 13 | 2022 |
| Cost and outcomes of implantable cardiac electronic device infections in Victoria, Australia C Roder, V Gunjaca, O Otome, SM Gwini, E Athan Heart, Lung and Circulation 29 (7), e140-e146, 2020 | 11 | 2020 |
| Psychiatrists can treat hepatitis C C Roder, P Nguyen, C Harvey, M Wardrop, J Finlay, L Ogunleye, H Hill, ... J Viral Hepat 28 (12), 1763-1764, 2021 | 4 | 2021 |
| Pregnancy–a key moment for engaging women with hepatitis B in care C Roder, S Chand, S Streat, S Beynon, E Huning, P Dabkowski, E Athan, ... Australian and New Zealand Journal of Public Health, 2021 | 4 | 2021 |
| Leave no-one behind: a retrospective study of hepatitis C testing and linkage to care for hospital inpatients C Roder, C Cosgrave, K Mackie, SK Roberts, ME Hellard, AJ Wade, ... Viruses 15 (4), 913, 2023 | 3 | 2023 |
| Effectiveness of direct‐acting antiviral therapy among Aboriginal and Torres Strait Islander peoples with HCV infection in Australia: A national real‐world cohort (REACH‐C) J Hudson‐Buhagiar, J Carson, S Monaghan, P Collie, R Nelson, ... Journal of Viral Hepatitis 30 (5), 386-396, 2023 | 1 | 2023 |
| Missed Opportunities: A Retrospective Study of Hepatitis C Testing in Hospital Inpatients C Roder, C Cosgrave, K Mackie, B McNamara, JS Doyle, AJ Wade Viruses 16 (6), 979, 2024 | | 2024 |
| Outreach nurses critical for delivery of HIV care to women in western Victoria AP Gador-Whyte, C Roder, R Hamilton, H Fay, E Huning, E Nicholson, ... Sexual Health, 2023 | | 2023 |
| Hospitalisation-missing an opportunity to link to hepatitis C care: a retrospective study at a regional Australian health service C Roder, C Cosgrave, K Mackie, B McNamara, J Doyle, A Wade Journal of Hepatology 78, S1190-S1191, 2023 | | 2023 |
| Improved care of pregnant women with chronic hepatitis B at Barwon Health after the implementation of a hepatitis B in pregnancy management algorithm S Chand, C Roder, A Wade Deakin University, 2023 | | 2023 |
| Successful expanded clinic network collaboration and patient tracing for retention in HIV care S Bhatt, M Bryant, H Lau, BK Tee, B Eu, J O’Bryan, I Woolley, J Mitchell, ... AIDS Research and Therapy 19 (1), 61, 2022 | | 2022 |
| S87 Discovery and validation of a personalised risk predictor for incident tuberculosis in settings aiming towards pre-elimination (PERISKOPE-TB) RK Gupta, CJ Calderwood, A Yavlinksy, M Krutikov, M Quartagno, ... Thorax 76 (Suppl 1), A53-A54, 2021 | | 2021 |
| Discovery and validation of a personalised risk predictor for incident tuberculosis in low transmission settings P Haldar, CJ Calderwood, A Yavlinsky, M Krutikov, M Quartagno, ... University of Leicester, 2020 | | 2020 |
Eugene AthanDeakin University, Barwon Health在 deakin.edu.au 的电子邮件经过验证
